Supplemental material
Modern Rheumatology
Volume 30, 2020 - Issue 1
Open access
1,562
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: Connective Tissue Diseases and Related Disorders
Efficacy and safety of adalimumab in Japanese patients with psoriatic arthritis and inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs): A prospective, observational study
Akimichi MoritaDepartment of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Correspondence[email protected]
http://orcid.org/0000-0001-8372-3754View further author information
Ryuhei OkuyamaDepartment of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
, Norito KatohDepartment of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Sciences, Kyoto, Japan; View further author information
, Chiharu TateishiDepartment of Dermatopathology, Osaka City University Graduate School of Medicine, Osaka, Japan; View further author information
, Koji MasudaDepartment of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Sciences, Kyoto, Japan; View further author information
, Toshifumi KomoriDepartment of Dermatology, Northern Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan; View further author information
, Eisaku OgawaDepartment of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
, Takamitsu MakinoDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; View further author information
, Emi NishidaDepartment of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; View further author information
, Shohei NishimotoEisai Co. Ltd., Tokyo, JapanView further author information
, Kenzo MuramotoEisai Co. Ltd., Tokyo, JapanView further author information
, Daisuke TsurutaDepartment of Dermatopathology, Osaka City University Graduate School of Medicine, Osaka, Japan; View further author information
& Hironobu IhnDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; View further author information
show all
Pages 155-165
|
Received 14 Sep 2018, Accepted 17 Feb 2019, Published online: 21 May 2019
Related Research Data
Infliximab in severe variants of psoriasis
Source:
Wiley
Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes
Source:
American Medical Association (AMA)
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
Source:
Informa Healthcare
Treatment with Biologicals in Rheumatoid Arthritis: An Overview
Source:
Springer Science and Business Media LLC
Tumor necrosis factor inhibitors in psoriatic arthritis
Source:
Informa UK Limited
Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study
Source:
The Journal of Rheumatology
Prevalence and treatment patterns of psoriatic arthritis in the UK
Source:
Oxford University Press (OUP)
Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
Source:
Springer Science and Business Media LLC
Adalimumab in psoriatic arthritis
Source:
The Journal of Rheumatology
The IL-23/IL-17 axis in psoriatic arthritis.
Source:
Elsevier BV
BASDAI and Psoriatic Arthritis
Source:
Wiley
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.